Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor.

Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor.
复制标题

DOI:
10.1016/j.bbagen.2012.04.008
复制
发表时间:
2012-07
影响因子:
3
通讯作者:
Kim, Jung Hoe
Kim, Jung Hoe
中科院分区:
生物学3区
文献类型:
--
作者:
Park, Seung-Yeol;Kwak, Chan-Yeong;Shayman, James A.;Kim, Jung Hoe

文献摘要

参考文献

被引文献

相似文献

Globoside (Gb4), a globo-series glycosphingolipid (GSL), has been characterized as a stage-specific embryonic antigen (SSEA), and is highly expressed during embryogenesis as well as in cancer tissues. However, the functional role and molecular mechanism of Gb4 is so far unknown. GSLs were preferentially inhibited by treatment with D-threo-1-ethylenedioxyphenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (EtDO-P4), a nanomolar inhibitor of GSL synthesis, in two carcinoma cell lines, HCT116 and MCF7. The effect of EtDO-P4 was examined by MTT assay, FACS analysis, wound assay, western blotting, and RTK array analysis. The functional role of Gb4 was determined by the exogenous addition of various GSLs, and an assay utilizing GSL-coated latex beads. Both cell lines contained higher levels of neutral GSLs than of sialic acid-containing GSLs. Gb4 was one of the major neutral GSLs. The depletion of total GSLs caused significant reduction of cell proliferation, but had less effect on cell apoptosis or motility. EtDO-P4 treatment also suppressed activation of the epidermal growth factor receptor (EGFR)-induced ERK pathway and various receptor tyrosine kinases (RTKs). The reduced activation of ERK was restored by the exogenous addition of Gb4, but not by the addition of gangliosides (GM1, GM2, GM3, GD1a). The GSL-coated bead assay indicated that Gb4 forms a complex with EGFR, but not with other RTKs. Gb4 promotes activation of EGFR-induced ERK signaling through direct interaction with EGFR. A globo-series GSL, Gb4, promotes EGFR-induced MAPK signaling, resulting in cancer cell proliferation. These findings suggest a possible application of Gb4 in cancer diagnostics and drug targeting.
DOI: 10.1038/nm.2171
发表时间: 2010-07
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Natoli, Thomas A.;Smith, Laurie A.;Rogers, Kelly A.;Wang, Bing;Komarnitsky, Svetlana;Budman, Yeva;Belenky, Alexei;Bukanov, Nikolay O.;Dackowski, William R.;Husson, Herve;Russo, Ryan J.;Shayman, James A.;Ledbetter, Steven R.;Leonard, John P.;Ibraghimov-Beskrovnaya, Oxana
通讯作者: Ibraghimov-Beskrovnaya, Oxana
DOI: 10.1042/bj0810384
发表时间: 1961-01-01
影响因子: 4.1
作者:
AMINOFF, D
通讯作者: AMINOFF, D
DOI: 10.1093/oxfordjournals.jbchem.a123667
发表时间: 1991-11-01
影响因子: 2.7
作者:
NAKAMURA, K;SUZUKI, M;SUZUKI, A
通讯作者: SUZUKI, A
DOI: 10.1023/a:1005986606010
发表时间: 1998-03-01
影响因子: 3.8
作者:
Nohara, K;Wang, F;Spiegel, S
通讯作者: Spiegel, S
DOI: 10.1016/0014-4827(89)90423-0
发表时间: 1989-07-01
影响因子: 3.7
作者:
STRAUS, AH;CARTER, WG;HAKOMORI, SI
通讯作者: HAKOMORI, SI